Gilead Sciences, Inc. 13D and 13G filings for Kyverna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-20 4:31 pm Purchase | 2024-02-12 | 13G | Kyverna Therapeutics, Inc. KYTX | GILEAD SCIENCES INC. GILD | 4,126,119 9.600% | 4,126,119 (New Position) | Filing |